Editorial: Covid-19 controversies: the Tocilizumab chapter
28 Jan, 2021 | 01:46h | UTCCovid-19 controversies: the tocilizumab chapter – The BMJ
Related: Contradicting earlier trials, Tocilizumab did not improve outcomes, with signs of harm, in patients with severe Covid-19 (studies and commentaries)